Experimental vaccine trains immune system to fight multiple cancers
Disease control
Completed
This study tested a cancer vaccine called ETBX-011 in 43 people with advanced colorectal, lung, breast, or prostate cancers that produce a protein called CEA. The vaccine uses a modified virus to teach the immune system to attack cancer cells making CEA. The main goals were to ch…
Phase: PHASE1, PHASE2 • Sponsor: NantCell, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC